Management of Vernal Keratoconjunctivitis

@inproceedings{Leonardi2013ManagementOV,
  title={Management of Vernal Keratoconjunctivitis},
  author={A Leonardi},
  booktitle={Ophthalmology and therapy},
  year={2013}
}
Vernal keratoconjunctivitis (VKC) is a relatively rare, chronic form of ocular allergy that can potentially cause severe visual complications. Affecting mainly children and young adults, it is an IgE- and T cell-mediated disease, leading to a chronic inflammation in which eosinophil, lymphocyte and structural cell activation are involved. Treatment of VKC requires a multiple approach that includes conservative measures and pharmacologic treatment. Patients and parents should be made aware of… CONTINUE READING

4 Figures & Tables

Connections & Topics

Mentioned Connections BETA
Immunomodulators that have been investigated for VKC treatment include topical ocular preparations of cyclosporine A and tacrolimus .
Immunomodulators that have been investigated for VKC treatment include topical ocular preparations of cyclosporine A and tacrolimus .
All Topics